RU96122561A - METHOD FOR COMPLEX THERAPY OF DISEASES - Google Patents

METHOD FOR COMPLEX THERAPY OF DISEASES

Info

Publication number
RU96122561A
RU96122561A RU96122561/14A RU96122561A RU96122561A RU 96122561 A RU96122561 A RU 96122561A RU 96122561/14 A RU96122561/14 A RU 96122561/14A RU 96122561 A RU96122561 A RU 96122561A RU 96122561 A RU96122561 A RU 96122561A
Authority
RU
Russia
Prior art keywords
drug
diseases
naringenin
treatment
dihydrocampferol
Prior art date
Application number
RU96122561/14A
Other languages
Russian (ru)
Other versions
RU2090205C1 (en
Inventor
В.К. Колхир
В.А. Быков
Н.А. Тюкавкина
Original Assignee
В.К. Колхир
В.А. Быков
Н.А. Тюкавкина
Filing date
Publication date
Application filed by В.К. Колхир, В.А. Быков, Н.А. Тюкавкина filed Critical В.К. Колхир
Priority to RU96122561A priority Critical patent/RU2090205C1/en
Priority claimed from RU96122561A external-priority patent/RU2090205C1/en
Application granted granted Critical
Publication of RU2090205C1 publication Critical patent/RU2090205C1/en
Publication of RU96122561A publication Critical patent/RU96122561A/en

Links

Claims (5)

1. Способ комплексной терапии заболеваний, включающий применение препаратов на основе биофлавоноидов, отличающийся тем, что лечение проводят препаратом Диквертин, представляющим собой сумму биофлавоноидов-дигидрокверцетина, дигидрокемпферола и нарингенина при следующем соотношении компонентов, мас.%:
Дигидрокверцетин - 90 - 92
Дигидрокемпферол и нарингенин - 8 - 10
причем нарингенина не более 2%, при суточной дозе 0,08 - 0,24 г.1. The method of complex treatment of diseases, including the use of drugs based on bioflavonoids, characterized in that the treatment is carried out with the drug Dikvertin, which is the sum of bioflavonoids-dihydroquercetin, dihydrocampferol and naringenin in the following ratio of components, wt.%:
Dihydroquercetin - 90 - 92
Dihydrocampferol and Naringenin - 8 - 10
moreover, naringenin is not more than 2%, with a daily dose of 0.08 - 0.24 g. 2. Способ по п. 1, отличающийся тем, что при бронхолегочных заболеваниях препарат используют в качестве патогенетической терапии. 2. The method according to p. 1, characterized in that for bronchopulmonary diseases, the drug is used as a pathogenetic therapy. 3. Способ по п. 1, отличающийся тем, что при ишемической болезни сердца и наджелудочковых нарушениях ритма препарат используют в сочетании с другими лекарственными средствами. 3. The method according to p. 1, characterized in that in ischemic heart disease and supraventricular rhythm disturbances, the drug is used in combination with other drugs. 4. Способ по пп. 1 - 3, отличающийся тем, что в остром периоде заболевания препарат применяют по 0,04 - 0,06 г 4 раза в сутки, а в период реконвалесценции по 0,02 г 4 раза в сутки. 4. The method according to PP. 1-3, characterized in that in the acute period of the disease, the drug is used at 0.04-0.06 g 4 times a day, and during convalescence, 0.02 g 4 times a day. 5. Способ по пп. 1 и 4, отличающийся тем, что курс лечения составляет 3 - 4 недели с возможностью повторения. 5. The method according to PP. 1 and 4, characterized in that the course of treatment is 3-4 weeks with the possibility of repetition.
RU96122561A 1996-12-02 1996-12-02 Method of complex therapy of diseases RU2090205C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96122561A RU2090205C1 (en) 1996-12-02 1996-12-02 Method of complex therapy of diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96122561A RU2090205C1 (en) 1996-12-02 1996-12-02 Method of complex therapy of diseases

Publications (2)

Publication Number Publication Date
RU2090205C1 RU2090205C1 (en) 1997-09-20
RU96122561A true RU96122561A (en) 1998-01-27

Family

ID=20187595

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96122561A RU2090205C1 (en) 1996-12-02 1996-12-02 Method of complex therapy of diseases

Country Status (1)

Country Link
RU (1) RU2090205C1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100523562B1 (en) * 2001-10-29 2005-10-25 한국과학기술연구원 Neuroprotective composition comprising an extract from opuntia ficus-indica and compounds isolated therefrom
RU2547692C1 (en) * 2014-02-13 2015-04-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for stimulating neoangiogenesis in ischemic skeletal muscle
RU2547786C1 (en) * 2014-02-13 2015-04-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for increasing skin graft survival in reduced circulation environment with use of dihydroquercetin

Similar Documents

Publication Publication Date Title
ATE241378T1 (en) COMBINATIONS OF VASOPRESSIN AND ADRENERGIC ACTIVES FOR THE TREATMENT OF SUDDEN CARDIAC DEATH
CA2092905A1 (en) Treatment of autoimmune diseases by oral administration of autoantigens
ATE83659T1 (en) USE OF INDOLON DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICALS FOR THE TREATMENT OF PARKINSONISM.
PT668763E (en) USE OF FENSERIN FOR THE PREPARATION OF MEDICINES TO TREAT DISEASES OF KNOWLEDGE
RU93055870A (en) BIPHENYL DERIVATIVES, THE METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERTENSION AND HEART DISEASES
DE69424777T2 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
ATE157871T1 (en) MEDICINAL PRODUCTS FOR THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF DISEASES CAUSED BY HYPERPLASIA OF SMOOTH MUSCLE CELLS
RU96122561A (en) METHOD FOR COMPLEX THERAPY OF DISEASES
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
CA2091134A1 (en) Therapeutic agent for threatened abortion
FR2613617B1 (en) MEDICINAL AGENTS FOR THE PREVENTION AND THERAPY OF RADIATION SKIN BURNS, CONTAINING 2,6-DIMETHYL-3,5-DIETHOXYCARBONYL-1,4-DIHYDROPYRIDINE AS ACTIVE INGREDIENT
DE551180T1 (en) Use of bucillamine in the manufacture of a medicament for the treatment of cystinuria.
DE69428797D1 (en) USE OF BENZYDAMINE TO TREAT DISEASES CAUSED BY TNF
BG60164B2 (en) Method for preparing of stereoisomers
IL82317A (en) 1,4-dihydropyridine derivatives,processes for their preparation and medicaments containing these compounds
RU96120483A (en) METHOD OF PREVENTION AND TREATMENT OF ENDOMETRITIS IN COWS
RU96106368A (en) MEDICINAL COLLECTION FOR TREATMENT AND PREVENTION OF UROLOGICAL DISEASES
RU96104214A (en) METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES
AU4259193A (en) Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
RU96117517A (en) METHOD FOR TREATING DIABETIC RETINOPATHY
RU95120783A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU92011168A (en) PREPARATION FOR THE TREATMENT OF GYNECOLOGICAL DISEASES
RU98109753A (en) METHOD FOR TREATING EXTRASYSTOLIA AND PAROXISMAL TACHYCARDIA
RU94004524A (en) BALSAMIC BIOLOGICALLY ACTIVE MEANS - FITAON - 3 AND METHOD OF ITS PREPARATION
RU98111356A (en) METHOD FOR TREATING BURN SHOCK